LRRK2 and Parkinson disease: We show clearly that LRRK2 mutations are present at a significant rate in patients with onset under 50 years (2.2%), and that SNCA mutations are present in 1.5% of patients with a strong family history of Parkinson’s disease (two or more additional family members affected).